Suppr超能文献

扁桃体鳞状细胞癌在转移情况下导致小肠穿孔及程序性死亡-1抑制剂治疗:一例报告

Squamous Cell Carcinoma of the Tonsil Causing Small Bowel Perforation in the Setting of Metastasis and Treatment With Programmed Death-1 Inhibitors: A Case Report.

作者信息

Dabek Robert J, Bizanti Anas, Thomas Samantha, Kalla Abhishek, Hamdallah Isam

机构信息

Department of Surgery, Saint Agnes Hospital, Baltimore, USA.

Department of Internal Medicine, Saint Agnes Hospital, Baltimore, USA.

出版信息

Cureus. 2020 Sep 30;12(9):e10739. doi: 10.7759/cureus.10739.

Abstract

Metastasis of extra-intestinal carcinoma to the gastrointestinal tract (GIT) is a rare event, most commonly occurring with malignant melanoma. Anti-PD-1 (programmed death-1) immunotherapeutic agents are immune checkpoint inhibitors with proven benefit across multiple cancer types, including squamous cell carcinoma of the head and neck (SCCHN). Here we describe a case of small bowel perforation attributed to a primary SCCHN metastasizing to the GIT in the setting of treatment with PD-1 inhibitors.

摘要

肠外癌转移至胃肠道(GIT)是一种罕见事件,最常见于恶性黑色素瘤。抗程序性死亡蛋白1(PD-1)免疫治疗药物是免疫检查点抑制剂,已被证明对多种癌症类型有效,包括头颈部鳞状细胞癌(SCCHN)。在此,我们描述了一例在接受PD-1抑制剂治疗期间,原发性SCCHN转移至GIT导致小肠穿孔的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951d/7529493/31898e76c641/cureus-0012-00000010739-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验